Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Business Model:
Revenue: $6.7M
Employees: 2-10
Address: 1134 Kline Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors. We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
Contact Phone:
+18583482180
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2017 | Smyte | Series A | 4M |
2/2013 | Simulmedia | Series C | 5M |
1/2015 | Primer | Seed Round | - |
1/2014 | Quippi | Venture Round | 2M |
11/2012 | Pingup | Series A | 4M |
6/2015 | Calporta Therapeutics | Series A | 10M |
12/2012 | Cheezburger | Venture Round | 5M |
1/2011 | Cheezburger | Venture Round | 30M |
5/2007 | Kaltura | Series A | 2.1M |
12/2000 | Ambit Biosciences | Series B | 18.8M |
2/2000 | ChoiceSeat technology | Venture Round | 22.4M |
11/2006 | Amira Pharmaceuticals | Series A | 4M |
7/2007 | Awarepoint | Series B | 2M |
3/2018 | Averon | Series A | 11.7M |
10/2017 | Averon | Series A | 8.3M |
3/2020 | AristaMD | Series B | 0 |
1/2010 | Pictela | Venture Round | 1.5M |
10/2011 | Chartio | Series A | 3.1M |
10/2018 | Seva Inc. | Seed Round | 2.4M |
7/2011 | Shelby.tv | Seed Round | 1.5M |
9/2014 | Kinvey | Series B | 10.9M |
6/2012 | Awarepoint | Venture Round | 14M |
11/2011 | Standing Cloud | Venture Round | 3M |
12/2008 | Awarepoint | Series D | 13.3M |
5/2005 | Ambit Biosciences | Series C | 31M |
2/2016 | Orion Labs | Series A | 9M |
5/2014 | BookBub | Series A | 3.8M |
6/2010 | Otonomy | Series A | 10M |
4/2010 | Cloudkick | Series A | 2M |
10/2012 | Selectable Media | Series A | 2M |
8/2011 | Nanigans | Series A | 3M |
3/2014 | Indix | Series A | 8.5M |
1/2015 | StackRox | Seed Round | - |
11/2008 | Selectable Media | Venture Round | 2.6M |
11/2010 | Standing Cloud | Series B | 3M |
10/2007 | Awarepoint | Series C | 3M |
11/2006 | Vocera Communications | Series F | 7M |
3/2011 | Tapad | Angel Round | 0 |
11/2017 | ScoreStream | Series A | 0 |
7/2012 | Shelby.tv | Series A | 2.2M |
10/2004 | Vocera Communications | Venture Round | 6M |
3/2006 | Awarepoint | Series A | 4M |
9/2014 | Avelas Biosciences | Series B | 7.4M |
1/2014 | Avelas Biosciences | Series B | 6.8M |
1/2009 | Pictela | Series A | 1.3M |
2/2005 | Cambrios Technologies | Series B | 12M |
4/2007 | Cambrios Technologies | Series C | 18.5M |
11/2009 | Cambrios Technologies | Series D | 14.5M |
12/2013 | Simulmedia | Series D | 25M |
12/2011 | Cloudant | Venture Round | 2.1M |
4/2013 | Indix | Series A | 6M |
10/2014 | MOGL | Venture Round | 11M |
7/2015 | AeroFS | Series B | 10M |
1/2015 | Primer | Venture Round | - |
8/2015 | Skycatch | Series B | 0 |
9/2013 | Otonomy | Series C | 45.9M |
8/2015 | MOGL | Venture Round | 7.9M |
10/2014 | Empyr | Venture Round | 11M |
3/2021 | Janux Therapeutics | Series A | 0 |
8/2016 | Avelas Biosciences | Series C | 0 |
10/2011 | TwinStrata | Series B | 8M |
6/2015 | Pronoun | Series B | 3.5M |
4/2015 | Cardeas Pharma | Series B | 37.5M |
7/2012 | Byliner | Series A | - |
5/2015 | Tapad | Series B | 0 |
9/2008 | Afraxis | Series A | 1.5M |
4/2013 | Proximal Data | Series B | 2M |
6/2010 | Chartio | Seed Round | 0 |
12/2017 | Pando | Seed Round | 3.1M |
6/2020 | Pando | Series A | 0 |
8/2021 | Jnana Therapeutics | Series B | 50M |
5/2014 | Skycatch | Venture Round | 13.2M |
9/2014 | Thyritope Biosciences | Series A | 10M |
10/2013 | Redbooth | Series A | 5M |
6/2017 | Talla | Series A | 8.3M |
7/2013 | Conjur | Seed Round | - |
1/2011 | Aratana Therapeutics | Series A | 0 |
8/2005 | Intercasting | Series A | 5.5M |
12/2015 | Enlibrium | Series A | 15M |
3/2013 | Tapad | Series B | 6.5M |
5/2007 | Intercasting | Series B | 12M |
2/2011 | RQx Pharmaceuticals | Series A | 7M |
10/2009 | JustSpotted | Seed Round | 750k |
6/2018 | Memrise | Series B | 15.5M |
4/2014 | Synthorx | Series A | 3.1M |
11/2012 | Kaltura | Series D | 25M |
11/2013 | Sitari Pharmaceuticals | Series A | 10M |
6/2015 | Cadherx Therapeutics | Series A | 10M |
9/2014 | Silarus Therapeutics | Series A | 10M |
2/2011 | MOGL | Series A | 2.4M |
12/2012 | Avelas Biosciences | Series A | 7.7M |
3/2008 | Chumby | Series B | 12.5M |
7/2012 | Kinvey | Series A | 5M |
7/2008 | Zynga | Series B | 25M |
11/2007 | AnaptysBio | Series B | 0 |
6/2015 | Indix | Series B | 15M |
4/2012 | Simulmedia | Series C | 6M |
2/2007 | Inogen | Series D | 22M |
5/2015 | BookBub | Series B | 7M |
11/2022 | Jnana Therapeutics | Series C | 0 |
8/2015 | Empyr | Venture Round | 7.9M |
10/2022 | Enlaza Therapeutics | Seed Round | 61M |
6/2014 | Tapad | Series B | 0 |
2/2014 | Sidecar Technologies | Series B | 10M |
1/2008 | Zynga | Series A | 0 |
2/2008 | Zynga | Series A | 5M |
3/2009 | Simulmedia | Series A | 4M |
5/2011 | Simulmedia | Series C | 9.3M |
4/2010 | Simulmedia | Series B | 8M |
6/2019 | Simulmedia | Series E | 29M |
9/2018 | Joy | Series A | 0 |
3/2020 | Orion Labs | Series B | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
7/2016 | Synthorx | Series B | 10M |
12/2011 | Aratana Therapeutics | Series B | 15M |
2/2014 | MOGL | Series B | 10.5M |
4/2007 | Syndax Pharmaceuticals | Series A | 40M |
12/2017 | Jnana Therapeutics | Series A | 50M |
2/2011 | Empyr | Series A | 2.4M |
1/2012 | Empyr | Series B | 12M |
3/2010 | Syndax Pharmaceuticals | Series A | 9M |
4/2014 | Otonomy | Series D | 49M |
8/2005 | Amira Pharmaceuticals | Series A | 3M |
12/2014 | Conjur | Venture Round | 2.6M |
7/2019 | Node | Venture Round | 0 |
9/2011 | Techstars | Venture Round | 24M |
4/2015 | ScoreStream | Seed Round | 3M |
6/2016 | Node | Seed Round | 7.5M |
6/2007 | Ortiva Wireless | Series B | 15M |
4/2010 | RethinkDB | Seed Round | 1.2M |
3/2010 | Ad Summos | Venture Round | 3M |
5/2013 | Cloudant | Series B | 12M |
9/2016 | Fortis Therapeutics | Series A | 18M |
3/2021 | Fortis Therapeutics | Series A | 0 |
9/2009 | Cloudkick | Seed Round | 750k |
12/2006 | Chumby | Series A | 5M |
3/2015 | Nanigans | Series B | 24M |
2/1999 | TomoTherapy | Series A | 3M |
12/2008 | Cloudant | Series A | 1M |
2/2017 | Piper Networks | Venture Round | 5.8M |
5/2018 | BotChain | Venture Round | 5M |
9/2010 | Backupify | Series A | 4.5M |
2/2015 | Overlap.cc | Pre Seed Round | - |
9/2021 | Joy | Series A | 0 |
1/2014 | Chartio | Venture Round | 2.2M |
7/2016 | AristaMD | Series A | 11M |
4/2017 | NanoNets | Seed Round | 1.4M |
11/2008 | Zacharon Pharmaceuticals | Series A | 3.5M |
3/2007 | Amira Pharmaceuticals | Series B | 25M |
4/2013 | Nanigans | Series A | 5.8M |
1/2012 | MOGL | Series B | 12M |
2/2011 | Kaltura | Series C | 20M |
1/2013 | LoopIt | Seed Round | - |
4/2018 | Synthorx | Series C | 63M |
6/2008 | Kaltura | Series B | 21M |
4/2020 | Figg | Funding Round | - |
4/2003 | Ansata Therapeutics | Series B | 2.5M |
6/2015 | Ankasa Regenerative Therapeutics | Series A | 8.5M |
11/2007 | BioVex | Series E | 35M |
10/2003 | BioVex | Series C | 28.4M |
2/1992 | Metra Biosystems | Venture Round | - |
10/2014 | StackIQ | Series B | 6M |
7/2014 | ScoreStream | Convertible Note | 800k |
9/2011 | RethinkDB | Series A | 0 |
5/2009 | E-Band Communications | Series C | - |
7/2006 | AnaptysBio | Series A | 2M |
9/2014 | Sidecar Technologies | Series C | 15M |
12/2015 | AlphaSheets | Seed Round | 5.5M |
10/2012 | Proximal Data | Series A | 3M |
2/2014 | Empyr | Series B | 10.5M |
5/2013 | Happy Cloud | Series A | 4.3M |
6/2006 | Kalon Semiconductor | Series A | 10.9M |
12/2010 | Cloudant | Series A | 1M |
6/2021 | Primer | Series C | 0 |
2/2012 | Memrise | Seed Round | 0 |
7/2012 | Backupify | Series C | 9M |
11/2014 | Redbooth | Series B | 11M |
6/2012 | Cardeas Pharma | Series A | 8.5M |
9/2011 | Backupify | Series B | 5M |
9/2021 | Joy | Series A | 0 |
8/2021 | Jnana Therapeutics | Series B | 0 |
6/2021 | Primer | Series C | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
3/2021 | Janux Therapeutics | Series A | 0 |
6/2020 | Pando | Series A | 0 |
4/2020 | Figg | Funding Round | - |
3/2020 | AristaMD | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|